PA
RCKT icon

Profund Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Profund Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226K Buy
+63,066
New +$251K 0.01% 949
2025
Q2 		– Sell
-32,285
Closed -$215K – 1037
2025
Q1 		$215K Buy
32,285
+2,124
+7% +$21K 0.01% 869
2024
Q4 		$379K Buy
30,161
+4,436
+17% +$66.8K 0.01% 659
2024
Q3 		$475K Buy
25,725
+3,524
+16% +$72.2K 0.02% 550
2024
Q2 		$478K Sell
22,201
-28,947
-57% -$665K 0.02% 517
2024
Q1 		$1.38M Buy
51,148
+16,677
+48% +$474K 0.05% 267
2023
Q4 		$1.03M Sell
34,471
-6,390
-16% -$141K 0.04% 323
2023
Q3 		$837K Sell
40,861
-1,641
-4% -$29.8K 0.05% 326
2023
Q2 		$845K Sell
42,502
-13,014
-23% -$263K 0.05% 355
2023
Q1 		$951K Buy
+55,516
New +$1.09M 0.06% 312

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return